Lv4
468 积分 2024-05-30 加入
Adequately defining tumor cell proportion in tissue samples for molecular testing improves interobserver reproducibility of its assessment
6天前
已完结
Metastatic Large-Cell Neuroendocrine Lung Carcinoma With ALK Fusion Oncogene With Partial Response to Alectinib
1个月前
已关闭
Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study
1个月前
已完结
Current therapy of advanced colorectal cancer according to RAS/RAF mutational status
1个月前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
2个月前
已完结
Design and Rationale for a Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Sugemalimab as Consolidation Therapy in Patients With Limited-Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent or Sequential Chemoradiotherapy: The SURPASS Study
3个月前
已完结
Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers
3个月前
已完结
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
3个月前
已完结
Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong’s perspective
4个月前
已完结
Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong’s perspective
4个月前
已完结
皖公网安备34019202002308
